Fachgruppe Binnenmarkt, Produktion, Verbrauch (INT) - Related Opinions

The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.

The objective of the initiative is to ensure the digitalisation of EU company law. In particular, the initiative will aim at enhancing transparency through increased availability of company information at EU level. It should enable the cross-border use of authentic and trustworthy data about companies, also through the application of the once-only principle, and make the existing rules and procedures fit for the digital age.

The exploratory opinion at the request of the incoming Spanish Presidency will look into advertising through influencers and its impact on consumers. Influencers as content creators with large numbers of followers on social networks have a crucial impact on consumer behaviour and, inter alia, on consumer decisions.

The opinion intends to contribute to the design of the EU regulation on critical raw materials and to its follow-up, and could influence the political and economic decisions to be taken at EU level in the new geopolitical context.